Expanding CBD options for patients through online prescription service
- Kanabo Group partners with British Cannabis for CBD supply
- CBD supplements will be available through Kanabo’s Treat It platform
- Partnership aims to enhance patient-centric healthcare and treatment options
Kanabo Group has announced a new partnership with British Cannabis to supply CBD supplements through its online prescription service, Treat It platform. This collaboration will allow Treat It doctors to offer a wider range of high-quality CBD supplements to patients, aiming to enhance patient-centric healthcare and treatment options. The CEO of Kanabo Group, Avihu Tamir, expressed excitement about the partnership and the opportunity to provide a broader range of CBD products to patients. As a result of this announcement, Kanabo Group’s shares saw a significant increase in value.
Factuality Level: 8
Factuality Justification: The article provides a straightforward report on Kanabo Group partnering with British Cannabis to make CBD supplements available through their online prescription service. The information is concise and does not contain any irrelevant or misleading details. The article does not include any sensationalism, redundancy, or opinion masquerading as fact. The reporting is objective and does not show any bias. Overall, the article appears to be well-researched and accurately reported.
Noise Level: 7
Noise Justification: The article provides some information about Kanabo Group’s partnership with British Cannabis and the availability of CBD supplements through their online prescription service. However, it lacks in-depth analysis, evidence, and actionable insights. The article also includes unrelated information about the company’s stock price, which is not relevant to the main topic.
Financial Relevance: Yes
Financial Markets Impacted: No
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Rating Justification: This news article pertains to the availability of British Cannabis’s CBD range of health supplements through Kanabo Group’s online prescription service. It does not mention any extreme events or financial market impacts.
Public Companies: Kanabo Group (N/A), British Cannabis (N/A)
Key People: Avihu Tamir (Chief Executive Officer)
www.marketwatch.com 
